Related Experiment Video
Updated: Jun 30, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
In vitro interspecies interactions between methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa:
Xinliang Peng1, Hang Zhou1, Wanchang Liu2
1Department of Orthopaedics, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Introduction:
Polymicrobial bone infections (PBIs) are associated with greater clinical severity and present more significant therapeutic challenges than monomicrobial infections. Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (PA) are the most frequently isolated pathogens in PBIs. However, despite previous studies have suggested both competitive and cooperative interactions between these two pathogens, their underlying molecular mechanisms and the impact on antibiotic susceptibility remain incompletely understood.
Methods:
Under in vitro co-culture conditions, bacterial growth and biofilm formation of MRSA and PA were evaluated by colony-forming unit (CFU) enumeration, crystal violet staining, and live/dead fluorescence staining. Minimum inhibitory concentrations (MICs) of clinically relevant antibiotics were determined for each species following co-culture to evaluate reciprocal alterations in antibiotic susceptibility. Additionally, RNA sequencing (RNA-seq) was performed on both species separately after co-culture to profile transcriptomic changes underlying their polymicrobial interaction.
Results:
At an MRSA: PA ratio of 1:1, MRSA CFU remained close to the initial inoculum throughout the experiment, with maximum CFU reaching only 1% of that in monoculture. MRSA biofilm biomass in the presence of PA cell-free supernatant was reduced by 33% at 36 hours. Notably, antibiotic susceptibility testing showed that MRSA exhibited increased MIC values for levofloxacin and daptomycin, with MICs 1.53 ± 0.00-fold and 2.00 ± 0.00-fold higher, respectively, than those in the monoculture group. Meanwhile, PA showed increased MIC values to colistin, with a 2.00 ± 0.00-fold higher MIC, but reduced MIC values for levofloxacin and ceftazidime, both showing a 0.50 ± 0.00-fold lower MIC compared with the monoculture group. Transcriptomic analysis of MRSA revealed significant increases in gene expression related to ribosome biogenesis, oxidative phosphorylation, and stress response pathways. PA co-cultured with MRSA downregulated multidrug-resistant efflux pump genes and upregulated pore-forming protein genes.
Conclusion:
PA inhibited MRSA growth in vitro co-culture at a 1:1 ratio, accompanied by altered antibiotic susceptibility profiles and transcriptional reprogramming. This study provides mechanistic insights into MRSA-PA interactions and establishes an experimental framework for developing targeted therapies against PBIs.
Insights
Pseudomonas aeruginosa (PA) inhibits Methicillin-resistant Staphylococcus aureus (MRSA) growth in polymicrobial bone infections (PBIs). This interaction alters antibiotic susceptibility and gene expression, offering insights for new PBI therapies.
Area of Science:
- Microbiology
- Infectious Diseases
- Genomics
Background:
- Polymicrobial bone infections (PBIs) are severe and challenging to treat.
- Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (PA) are common pathogens in PBIs.
- The molecular mechanisms and impact on antibiotic susceptibility of MRSA-PA interactions are not fully understood.
Purpose of the Study:
- To investigate the in vitro interaction between MRSA and PA.
- To evaluate the impact of this interaction on bacterial growth, biofilm formation, and antibiotic susceptibility.
- To analyze the transcriptomic changes in MRSA and PA during co-culture.
Main Methods:
- In vitro co-culture of MRSA and PA.
- Colony-forming unit (CFU) enumeration, crystal violet staining, and live/dead fluorescence staining for growth and biofilm assessment.
- Minimum inhibitory concentration (MIC) determination for antibiotic susceptibility testing.
- RNA sequencing (RNA-seq) for transcriptomic profiling.
Main Results:
- PA inhibited MRSA growth at a 1:1 ratio, reducing MRSA CFU by 99% and biofilm biomass by 33%.
- MRSA showed increased resistance to levofloxacin and daptomycin, while PA exhibited increased resistance to colistin but decreased resistance to levofloxacin and ceftazidime.
- Transcriptomic analysis revealed altered gene expression in both species, including upregulation of stress response pathways in MRSA and downregulation of efflux pumps in PA.
Conclusions:
- PA inhibits MRSA growth in vitro, altering antibiotic susceptibility and transcriptomic profiles.
- These findings provide mechanistic insights into MRSA-PA interactions in PBIs.
- The study establishes a framework for developing targeted therapies against polymicrobial bone infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
